Clinical Trial Update: Safety and Efficacy of PMT Therapy of hPAP [Phase 1, Phase 2]

View source ↗

Summary

The document provides a clinical trial update on the safety and efficacy of PMT Therapy for hereditary pulmonary alveolar proteinosis, with Phase 1 and Phase 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Pulmonary Alveolar Proteinosis

Drugs mentioned

• PMT Therapy

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hereditary Pulmonary Alveolar Proteinosis | Phase 1, Phase 2 | Status: RECRUITING